Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, octubre 20
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
111 Inc
YI
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$3.13
0.005
0.16%
Últ. Act.: Oct 7, 5:38 PM
$3.25
0.12
3.83%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Privacy Manager
111 Financials
111 (YI) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
China's 111 Inc. Gets Buyout Proposal From Co-Founders in Going-Private Push
111 Inc. (YI) reports Q2 2026 results with widened net loss, a shift to asset-light model, and an unsolicited $4.52/ADS privatization bid.
Akanksha Bakshi
Earnings Scheduled For September 17, 2026
Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its second quarter. • Innate Pharma (NASDAQ:IPHA) is projected to report quarterly loss at $0.16 per share on revenue of $9.10
Benzinga Insights
PRO
111 Q2 Adj. EPS $(0.60) Down From $(0.40) YoY, Sales $338.995M Down From $447.507M YoY
111 (NASDAQ:YI) reported quarterly losses of $(0.60) per share. This is a 50 percent decrease over losses of $(0.40) per share from the same period last year. The company reported $338.995 million in sales this
Benzinga Newsdesk
PRO
111 Q1 Adj. EPS $(0.60) Down From $(0.20) YoY, Sales $342.400M Down From $486.348M YoY
111 (NASDAQ:YI) reported quarterly losses of $(0.60) per share. This is a 200 percent decrease over losses of $(0.20) per share from the same period last year. The company reported $342.400 million in sales this
Benzinga Newsdesk
Earnings Scheduled For April 9, 2026
Benzinga Insights
PRO
111 Q4 Adj. EPS $(0.20) Down From $(0.04) YoY, Sales $403.278M Down From $527.143M YoY
111 (NASDAQ:YI) reported quarterly losses of $(0.20) per share. This is a 400 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $403.278 million in sales this
Benzinga Newsdesk
